Barbara L. Mui
- Molecular Biology top 1%
- Immunology top 2%
- Infectious Diseases top 1%
- Genetics top 2%
- Biomaterials top 2%
- Co-authors
- Michael J. HopeThomas D. MaddenYing K. TamPieter R. CullisSteven M. AnsellDrew WeissmanNorbert PardiMuthusamy Jayaraman
- Topics
- RNA Interference and Gene Delivery (26 papers)Advanced biosensing and bioanalysis techniques (10 papers)Virus-based gene therapy research (7 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Barbara L. Mui
35 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Biology 5.2k
- Immunology 1.3k
- Infectious Diseases 1.2k
- Genetics 1.0k
- Biomaterials 671
Countries citing papers authored by Barbara L. Mui
This map shows the geographic impact of Barbara L. Mui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara L. Mui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara L. Mui more than expected).
Fields of papers citing papers by Barbara L. Mui
This network shows the impact of papers produced by Barbara L. Mui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara L. Mui. The network helps show where Barbara L. Mui may publish in the future.
Co-authorship network of co-authors of Barbara L. Mui
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara L. Mui. A scholar is included among the top collaborators of Barbara L. Mui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara L. Mui. Barbara L. Mui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 24 | |
| 5 | 11 | |
| 6 | 18 | |
| 7 | The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugsbreakdown → | 1160 |
| 8 | 69 | |
| 9 | 58 | |
| 10 | 75 | |
| 11 | PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptakebreakdown → | 154 |
| 12 | Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodiesbreakdown → | 201 |
| 13 | Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challengebreakdown → | 267 |
| 14 | Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**breakdown → | 973 |
| 15 | Encapsulation of crystalline topotecan in sphingosomes: a formulation suitable for clinical development | 1 |
| 16 | 125 | |
| 17 | 184 | |
| 18 | 43 | |
| 19 | 68 | |
| 20 | 188 |
About Barbara L. Mui
Barbara L. Mui is a scholar working on Molecular Biology, Virology and Immunology, having authored 36 papers that have together received 6.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (26 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Molecular Biology (5.2k citations), Infectious Diseases (1.2k citations) and Immunology (1.3k citations). Barbara L. Mui has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Michael J. Hope, Thomas D. Madden, Ying K. Tam, Pieter R. Cullis, Steven M. Ansell, Drew Weissman, Norbert Pardi, Muthusamy Jayaraman, Xinyao Du and Muthiah Manoharan. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.